NVLPF
Price
$0.22
Change
+$0.03 (+15.79%)
Updated
Aug 8 closing price
Capitalization
17.79M
ORPEF
Price
$14.22
Change
+$0.37 (+2.67%)
Updated
Jul 22 closing price
Capitalization
2.45B
Interact to see
Advertisement

NVLPF vs ORPEF

Header iconNVLPF vs ORPEF Comparison
Open Charts NVLPF vs ORPEFBanner chart's image
Nova Leap Health
Price$0.22
Change+$0.03 (+15.79%)
Volume$3.7K
Capitalization17.79M
Orpea ACT
Price$14.22
Change+$0.37 (+2.67%)
Volume$400
Capitalization2.45B
NVLPF vs ORPEF Comparison Chart in %
Loading...
NVLPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVLPF vs. ORPEF commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVLPF is a Hold and ORPEF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (NVLPF: $0.22 vs. ORPEF: $14.22)
Brand notoriety: NVLPF and ORPEF are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: NVLPF: 47% vs. ORPEF: 100%
Market capitalization -- NVLPF: $17.79M vs. ORPEF: $2.45B
NVLPF [@Hospital/Nursing Management] is valued at $17.79M. ORPEF’s [@Hospital/Nursing Management] market capitalization is $2.45B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $89.29B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVLPF’s FA Score shows that 1 FA rating(s) are green whileORPEF’s FA Score has 0 green FA rating(s).

  • NVLPF’s FA Score: 1 green, 4 red.
  • ORPEF’s FA Score: 0 green, 5 red.
According to our system of comparison, NVLPF is a better buy in the long-term than ORPEF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVLPF’s TA Score shows that 4 TA indicator(s) are bullish.

  • NVLPF’s TA Score: 4 bullish, 3 bearish.

Price Growth

NVLPF (@Hospital/Nursing Management) experienced а +27.53% price change this week, while ORPEF (@Hospital/Nursing Management) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +4.97%. For the same industry, the average monthly price growth was -2.57%, and the average quarterly price growth was +9.25%.

Industries' Descriptions

@Hospital/Nursing Management (+4.97% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORPEF($2.45B) has a higher market cap than NVLPF($17.8M). NVLPF has higher P/E ratio than ORPEF: NVLPF (21.96) vs ORPEF (0.03). NVLPF YTD gains are higher at: 9.992 vs. ORPEF (0.000).
NVLPFORPEFNVLPF / ORPEF
Capitalization17.8M2.45B1%
EBITDA1.97MN/A-
Gain YTD9.9920.000-
P/E Ratio21.960.0382,609%
Revenue26.4MN/A-
Total Cash1.33MN/A-
Total Debt3.34MN/A-
FUNDAMENTALS RATINGS
NVLPF vs ORPEF: Fundamental Ratings
NVLPF
ORPEF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8590
PRICE GROWTH RATING
1..100
4670
P/E GROWTH RATING
1..100
998
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVLPF's Valuation (62) in the null industry is in the same range as ORPEF (92). This means that NVLPF’s stock grew similarly to ORPEF’s over the last 12 months.

NVLPF's Profit vs Risk Rating (100) in the null industry is in the same range as ORPEF (100). This means that NVLPF’s stock grew similarly to ORPEF’s over the last 12 months.

NVLPF's SMR Rating (85) in the null industry is in the same range as ORPEF (90). This means that NVLPF’s stock grew similarly to ORPEF’s over the last 12 months.

NVLPF's Price Growth Rating (46) in the null industry is in the same range as ORPEF (70). This means that NVLPF’s stock grew similarly to ORPEF’s over the last 12 months.

NVLPF's P/E Growth Rating (9) in the null industry is significantly better than the same rating for ORPEF (98). This means that NVLPF’s stock grew significantly faster than ORPEF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVLPFORPEF
RSI
ODDS (%)
Bearish Trend 4 days ago
80%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
73%
N/A
Momentum
ODDS (%)
Bullish Trend 4 days ago
67%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
63%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
24%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
18%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
75%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NVLPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THLCX23.770.19
+0.81%
Thrivent Large Cap Growth S
AMRMX60.290.28
+0.47%
American Funds American Mutual A
TCBIX8.850.03
+0.34%
Covered Bridge I
VVJFX75.350.09
+0.12%
Voya Multi-Manager Intl Sm Cp R6
NRICX22.15-0.05
-0.23%
Nuveen Real Asset Income C

NVLPF and

Correlation & Price change

A.I.dvisor tells us that NVLPF and LTGHY have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVLPF and LTGHY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVLPF
1D Price
Change %
NVLPF100%
+18.70%
LTGHY - NVLPF
6%
Poorly correlated
+0.31%
JRSS - NVLPF
3%
Poorly correlated
N/A
HLYK - NVLPF
1%
Poorly correlated
-6.02%
KJFI - NVLPF
-0%
Poorly correlated
N/A
ORPEF - NVLPF
-1%
Poorly correlated
N/A
More

ORPEF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORPEF has been loosely correlated with DCGO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ORPEF jumps, then DCGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORPEF
1D Price
Change %
ORPEF100%
N/A
DCGO - ORPEF
37%
Loosely correlated
+12.95%
MFCSF - ORPEF
4%
Poorly correlated
-0.67%
KJFI - ORPEF
0%
Poorly correlated
N/A
JRSS - ORPEF
-0%
Poorly correlated
N/A
NWKHY - ORPEF
-0%
Poorly correlated
N/A
More